Biocon’s fundraising is viewed positively to manage debt. Expert Nischal Maheshwari is optimistic about Biocon’s future, expecting earlier investments to yield returns. He also favors contract development and manufacturing firms like Laurus Labs. Maheshwari sees potential in banking, metals, and power sectors, particularly execution-focused players in power.
Ahead of Market: 10 things that will decide stock market action on Monday
Indian equities extended losses for a fifth straight session, pressured by elevated oil prices and persistent FII outflows. Despite intraday recovery, sentiment remains weak amid